Pirfenidone Viatris Den europeiske union - norsk - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dapagliflozin Viatris Den europeiske union - norsk - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - legemidler som brukes i diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Den europeiske union - norsk - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influensavirusoverflateantigener (hemagglutinin og neuraminidase) av stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaksiner - aktiv immunisering mot h5n1 subtype av influensa a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Bortezomib Viatris 3.5 mg Norge - norsk - Statens legemiddelverk

bortezomib viatris 3.5 mg

viatris limited - bortezomibmannitolboronat - pulver til injeksjonsvæske, oppløsning - 3.5 mg

Amoxicillin Viatris 500 mg Norge - norsk - Statens legemiddelverk

amoxicillin viatris 500 mg

viatris limited - amoksicillintrihydrat - kapsel, hard - 500 mg

Amoxicillin Viatris 250 mg Norge - norsk - Statens legemiddelverk

amoxicillin viatris 250 mg

viatris limited - amoksicillintrihydrat - kapsel, hard - 250 mg

Amoxicillin Viatris 750 mg Norge - norsk - Statens legemiddelverk

amoxicillin viatris 750 mg

viatris limited - amoksicillintrihydrat - tablett, filmdrasjert - 750 mg

Mianserin Viatris 30 mg Norge - norsk - Statens legemiddelverk

mianserin viatris 30 mg

viatris limited - mianserinhydroklorid - tablett, filmdrasjert - 30 mg

Mianserin Viatris 10 mg Norge - norsk - Statens legemiddelverk

mianserin viatris 10 mg

viatris limited - mianserinhydroklorid - tablett, filmdrasjert - 10 mg

Fluoxetin Viatris 20 mg Norge - norsk - Statens legemiddelverk

fluoxetin viatris 20 mg

viatris limited - fluoksetinhydroklorid - kapsel, hard - 20 mg